Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 105 is a human genomic sequence closely related in structure to the functional 5S ribosomal RNA gene but classified as a pseudogene[6]. Pseudogenes are generally non-functional, arising via gene duplication or retrotransposition events, and accumulate mutations that preclude their translation or normal RNA function[2]. Some pseudogenes may be transcribed into non-coding RNAs, which can exert regulatory effects on parental genes, typically by competing for endogenous microRNA binding (ceRNA mechanism) or by facilitating epigenetic chromatin modifications[2]. There is no evidence that RNA5SP105 encodes a receptor, transporter, enzyme, or any other conventional drug target, nor is there evidence of clinical relevance, interacting drugs, or function as a biomarker. It should not be listed as a therapeutic target; its annotation is correct from a genomic perspective, but inappropriate for lists of actionable molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 105 (RNA5SP105).